MakeMyTrip (NASDAQ:MMYT) reported quarterly adj earnings of $0.07 per share which beat the analyst consensus estimate of $(0.07) by 200 percent. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $156.80 million which beat the analyst consensus estimate of $156.73 million by 0.04 percent. This is a 81.48 percent increase over sales of $86.40 million the same period last year.
MakeMyTrip Q2 Adj EPS $0.07 Beats $(0.07) Estimate, Sales $156.80M Beat $156.73M Estimate
MakeMyTrip (NASDAQ:MMYT) reported quarterly adj earnings of $0.07 per share which beat the analyst consensus estimate of $(0.07) by 200 percent. This is a 22.22 percent decrease over earnings of $0.09 per share from the
Related Posts
Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS (Voclosporin) in Japan
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company) today announced that the Company's collaboration partner, Otsuka Pharmaceutical Ltd., filed a new drug application (NDA) for voclosporin for the
Datadog Analyst Highlights Growth Versus Public Cloud Providers And Cost Monitoring Versus Pandemic Times
Needham analyst Mike Cikos reiterated a Buy and $90 price target on Datadog, Inc (NASDAQ:DDOG) Since Datadog’s earnings release, client feedback has centered…
Dollar Tree Gets Price Target Cuts By Analysts After Q1 Results
Dollar Tree Inc (NASDAQ: DLTR) reported mixed first-quarter financial results and issued guidance.